Target intelligence / Profile preview

High mobility group box 1 pseudogene 17 (HMGB1P17)

Target: HMGB1P17
Molecular classification: Other, Pseudogene

Overview

High mobility group box 1 pseudogene 17 (HMGB1P17) is a processed pseudogene related to the HMGB1 gene. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional as protein-coding genes due to accumulated mutations, absence of regulatory elements, or lack of transcription/translation[1][4]. HMGB1P17 is presently defined only by its sequence similarity to HMGB1, and there is no experimental evidence that it is transcribed, translated, or involved in biological regulation or disease. In general, most pseudogenes are not considered therapeutic targets or biomarkers[1][4].

Other names: High Mobility Group Box 1 Pseudogene 17HMGB1P17

Beyond the preview

Go deeper on High mobility group box 1 pseudogene 17 (HMGB1P17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 1 pseudogene 17 (HMGB1P17).

Explore the full profile